尿酸白蛋白比值对冠状动脉慢血流的预测价值分析

doi:10.3969/j.issn.1006-6233.2024.07.014

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1425 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the correlation between uric acid albumin ratio (UAR) and coronary slow flow (CSF) and evaluate the predictive value of UAR for CSF. Methods: A retrospective analysis was conducted on 610 patients with chest pain who underwent coronary angiography at the Heart Center of Xinjiang Medical University. Electronic medical records and coronary angiography results were collected, and patients were grouped according to the presence or absence of CSF. Multivariable-adjusted methods were used to assess the correlation between uric acid (UA), albumin (ALB), and UAR and the occurrence of CSF. ROC curves and RCS curves were used to evaluate the relationship between the above indicators and CSF risk. Results: Compared with the control group, the CSF group had a higher proportion of males and higher rates of smoking and alcohol consumption. The CSF group had higher body mass index (BMI), hemoglobin (Hb), aspartate aminotransferase (AST), UA, and UAR levels, and lower ALB levels (P<0.05).Multivariable-adjusted logistic regression analysis showed that high UA levels (OR: 1.010, 95%CI: 1.007-1.013, P<0.001), UAR (OR: 1.513, 95%CI: 1.341-1.707, P<0.001), and low ALB levels (OR: 0.794, 95%CI: 0.733-0.860, P<0.001) were independent risk factors for CSF.ROC curve analysis showed that UA, ALB, and UAR all had good predictive value for CSF, among which UAR had the best performance (P<0.05).RCS curve analysis showed that UAR and CSF risk were generally positively correlated. Conclusion: The results suggest that UAR is associated with CSF and may be a useful biomarker for predicting CSF.

Key words： Coronary slow flow Uric acid Albumin Urine albumin creatinine ratio

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HANIKEZI kasimu
	MIHAILI Maranmu
	MA Yitong

Cite this article:

HANIKEZI kasimu,MIHAILI Maranmu,MA Yitong. Predictive Value of Uric Acid Albumin Ratio for Coronary Slow Flow Phenomenon[J]. HeBei Med, 2024, 30(7): 1134-1139.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2024.07.014 OR http://www.hbyxzzs.cn/EN/Y2024/V30/I7/1134

[1] Elsanan M, Tahoon I, Mohamed G I, et al. Predictors of non-obstructive coronary slow flow in poorly controlled type 2 diabetes mellitus: a cross-sectional study [J]. BMC Cardiovasc Disord, 2024, 24(1): 83.
[2] Yu J, Yi D, Yang C, et al. Major adverse cardiovascular events and prognosis in patients with coronary slow flow [J]. Curr Probl Cardiol, 2024, 49(1): 102074.
[3] Saito Y, Tanaka A, Node K, et al. Uric acid and cardiovascular disease: a clinical review [J]. Cardiol, 2021, 78(1): 51-7.
[4] Manolis A A, Manolis T A, Melita H, et al. Low serum albumin: a neglected predictor in patients with cardiovascular disease [J]. Eur Intern Med, 2022(102): 24-39.
[5] Cakmak E O, Bayam E, Celik M, et al. Uric acid-to-albumin ratio: a novel marker for the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction [J]. Pulse (Basel), 2021, 8(3-4): 99-107.
[6] Yang Z, Yuan J, Cui J, et al. Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia [J]. BMC Cardiovasc Disord, 2021, 21(1): 156.
[7] Saylik F, Cinar T, Selcuk M, et al. The relationship between uric acid/albumin ratio and carotid intima-media thickness in patients with hypertension [J]. Arq Bras Cardiol, 2023, 120(5): e20220819.
[8] Yalcinkaya D, Karacali K, Ilhan B C, et al. Relation between serum uric acid to albumin ratio and severity of chronic coronary artery disease [J]. Angiology, 2024, 75(4): 386-393.
[9] Li S, Chen H, Zhou L, et al. The uric acid to albumin ratio: a novel predictor of long-term cardiac mortality in patients with unstable angina pectoris after percutaneous coronary intervention [J]. Scand Clin Lab Invest, 2022, 82(4): 304-310.
[10] Cinar T, Saylik F, Hayiroglu M I, et al. The association of serum uric acid/albumin ratio with no-reflow in patients with ST elevation myocardial infarction [J]. Angiology, 2023, 74(4): 381-386.
[11] Mandurino-mirizzi A, Demarchi A, Ruffinazzi M, et al. Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction [J]. Cardiovasc Med (Hagerstown), 2020, 21(4): 337-339.
[12] Niu Y, Zhang H, Li X D, et al. Uric acid is associated with worsening of diastolic function and adverse outcomes in patients with coronary slow flow [J]. Turk Kardiyol Dern Ars, 2023, 51(1): 3-9.